Yasuhiro Yamamoto

Yasuhiro Yamamoto

Auto-generated profile, based on publicly available information

Yasuhiro Yamamoto

Department of Surgery, Kobayashi Hospital

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1995 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
Eri YoshidaEri Yoshida
Eri Yoshida
YFYoshihiro Fujimura
Yoshihiro Fujimura
YIYasuo Ikeda
Yasuo Ikeda
ITIchiroh Takeda
Ichiroh Takeda
YYYasuhiro Yamamoto
Yasuhiro Yamamoto
NNNobuhiro Narita
Nobuhiro Narita

25 May 2015 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
SKShinichi Komiyama
Shinichi Komiyama
CTChiaki Takeya
Chiaki Takeya
RTRena Takahashi
Rena Takahashi
YYYasuhiro Yamamoto
Yasuhiro Yamamoto
KKKaneyuki Kubushiro
Kaneyuki Kubushiro

1 January 2008 in Journal of Receptors and Signal Transduction
Verified
Journal Article
Closed access
MYMakoto Yono
Makoto Yono
YYYasuhiro Yamamoto
Yasuhiro Yamamoto
AIAya Imanishi
Aya Imanishi
MYMasaki Yoshida
Masaki Yoshida
SUShoichi Ueda
Shoichi Ueda
JLJamshid Latifpour
Jamshid Latifpour
We compared the effects of two alpha(1)-adrenoceptor antagonists with different selectivity for the alpha(1)-adrenoceptor subtypes, prazosin and naftopidil, on pelvic blood flow and nitric oxide synthase (NOS) levels in the spontaneously hypertensive rat (SHR). SHRs and normotensive Wistar-Kyoto (WKY) rats were distributed initially in four groups: group 1 received prazosin, a subtype nonselective alpha(1)-adrenoceptor antagonist (2 mg/kg/day); group 2 received naftopidil, a selective alpha(1A/D)-adrenoceptor antagonist (10 mg/kg/day); group 3 received cyclazosin, a selective alpha(1B)-adrenoceptor antagonist (5 mg/kg/day); and group 4 received the vehicle orally for 4 weeks. Pelvic blood flow was determined by using a fluorescent microsphere infusion technique. Expression levels of nNOS and eNOS mRNAs in the rat genitourinary tissues were quantified by real-time reverse transcription polymerase chain reaction (RT-PCR) using SYBR Green I. The characteristics of alpha(1)-adrenoceptors in the rat iliac artery were determined by using radioligand receptor binding and real-time RT-PCR techniques. Untreated SHRs had lower blood flow to the ventral prostate, dorsolateral prostate, urinary bladder, and penis and lower mRNA expression levels of nNOS in the bladder and penis and eNOS in the penis than untreated WKY rats. Naftopidil had no significant effects on blood flow and NOS levels, whereas administration of prazosin and cyclazosin to the SHR caused a significant increase in blood flow to each tissue studied and a significant increase in expression levels of these genes. The density of total alpha(1)-adrenoceptors was significantly higher in iliac arteries of untreated SHRs than those of untreated WKY rats. RT-PCR data indicated that alpha(1B)-adrenoceptor mRNA was the significantly predominant gene transcript in iliac arteries of untreated SHRs. Our data show that prazosin, but not naftopidil, causes differential alterations in NOS levels in the SHR genitourinary tract, which could be due to increased pelvic blood flow resulting from inhibiting the vascular alpha(1B)-adrenoceptor. These findings may provide insight into the beneficial effects of subtype nonselective alpha(1)-adrenoceptor antagonists on prostate, bladder, and penile function, when used to treat symptoms of benign prostatic hyperplasia and elevated blood pressure.

1 June 2017 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
PDF file
TSTakumi Saito
Takumi Saito
YYYasuhiro Yamamoto
Yasuhiro Yamamoto
GFGuo-Gang Feng
Guo-Gang Feng
YKYoshiaki Kazaoka
Yoshiaki Kazaoka
YFYoshihiro Fujiwara
Yoshihiro Fujiwara
HKHiroyuki Kinoshita
Hiroyuki Kinoshita
BACKGROUND: Periodontal inflammation causes endothelial dysfunction of the systemic artery. However, it is unknown whether the use of local anesthetics during painful dental procedures alleviates periodontal inflammation and systemic endothelial function. This study was designed to examine whether the gingival or systemic injection of lidocaine prevents oxidative stress-induced endothelial dysfunction of the systemic artery in rats with intermittent periodontal inflammation caused by lipopolysaccharides (LPS). METHODS: Some rats received 1500 µg LPS injections to the gingiva during a week interval from the age of 8 to 11 weeks (LPS group). Lidocaine (3 mg/kg), LPS + lidocaine (3 mg/kg), LPS + lidocaine (1.5 mg/kg), and LPS + lidocaine (3 mg/kg, IP) groups simultaneously received gingival 1.5 or 3 mg/kg or IP 3 mg/kg injection of lidocaine on the same schedule as the gingival LPS. Isolated aortas or mandibles were subjected to the evaluation of histopathologic change, isometric force recording, reactive oxygen species, and Western immunoblotting. RESULTS: Mean blood pressure and heart rate did not differ among the control, LPS, LPS + lidocaine (3 mg/kg), and lidocaine (3 mg/kg) groups. LPS application reduced acetylcholine (ACh, 10–9 to 10–5 mol/L)-induced relaxation (29% difference at ACh 3 × 10–8 mol/L, P = .01), which was restored by catalase. Gingival lidocaine (1.5 and 3 mg/kg) dose dependently prevented the endothelial dysfunction caused by LPS application (24.5%–31.1% difference at ACh 3 × 10–8 mol/L, P = .006 or .001, respectively). Similar to the gingival application, the IP injection of lidocaine (3 mg/kg) restored the ACh-induced dilation of isolated aortas from rats with the LPS application (27.5% difference at ACh 3 × 10–8 mol/L, P < .001). Levels of reactive oxygen species were double in aortas from the LPS group (P < .001), whereas the increment was abolished by polyethylene glycol-catalase, gingival lidocaine (3 mg/kg), or the combination. The LPS induced a 4-fold increase in the protein expression of tumor necrosis factor-α in the periodontal tissue (P < .001), whereas the lidocaine (3 mg/kg) coadministration partly reduced the levels. Lidocaine application also decreased the protein expression of the nicotinamide adenine dinucleotide phosphate oxidase subunit p47phox, which was enhanced by the gingival LPS (5.6-fold increase; P < .001). CONCLUSIONS: Lidocaine preserved the aortic endothelial function through a decrease in arterial reactive oxygen species produced by nicotinamide adenine dinucleotide phosphate oxidase and periodontal tumor necrosis factor-α levels in rats with periodontal inflammation. These results suggest the beneficial effect of the gingival application of local anesthetics on the treatment of periodontal diseases on endothelial function of systemic arteries.

1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
YYYasuhiro Yamamoto
Yasuhiro Yamamoto
TSTakumi Saito
Takumi Saito
GFGuo-Gang Feng
Guo-Gang Feng
JLJiazheng Li
Jiazheng Li
YYYoshitaka Yasuda
Yoshitaka Yasuda
HKHiroyuki Kinoshita
Hiroyuki Kinoshita

1 December 2019 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
YYYasuhiro Yamamoto
Yasuhiro Yamamoto
NANobuhiro Asai
Nobuhiro Asai
AFAkifumi Furuhashi
Akifumi Furuhashi
TOTakayuki Ono
Takayuki Ono
YYYuka Yamagishi
Yuka Yamagishi
YKYoshiaki Kazaoka
Yoshiaki Kazaoka